CLARITY-Gastric 01: A randomized phase 3 study of sonesitatug vedotin (sone ve), a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC).

  • Shitara, Kohei; 
  • Janjigian, Yelena Y.; 
  • Elimova, Elena; 
  • Zhang, Jun; 
  • Chen, Ming-Huang; 
  • ... Lee, Jeeyun; 
  • 외 6명
Citations

WEB OF SCIENCE

1
제목
CLARITY-Gastric 01: A randomized phase 3 study of sonesitatug vedotin (sone ve), a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC).
저자
Shitara, Kohei; Janjigian, Yelena Y.; Elimova, Elena; Zhang, Jun; Chen, Ming-Huang; Smyth, Elizabeth Catherine; Lee, Jeeyun; Miao, Rui; Liu, Silver; Holmblad, Marielle; Rahma, Osama E.; Xu, Rui-Hua
DOI
10.1200/JCO.2026.44.2_suppl.TPS462
발행일
2026-01
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
권
44
호
2_SUPPL
페이지
TPS462 ~ TPS462